川东北地区食管鳞状细胞癌血清肿瘤标志物的诊断效能
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

川北医学院附属医院科研发展计划项目(2022JC018);


Diagnostic efficacy of serum tumor markers for esophageal squamous cell carcinoma in northeast Sichuan province
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的:探讨川东北地区食管鳞状细胞癌(ESCC)血清肿瘤标志物的诊断效能。方法:RT-qPCR检测46例ESCC患者(观察组)与46名健康体检志愿者(对照组)食管组织和血清中miR-222-5p的表达差异,分析ESCC患者血清miR-222-5p的表达水平与不同临床病理特征的相关性及其对ESCC的诊断效能。结果:观察组患者血清miR-222-5p水平高于对照组[(1.76±0.99)vs.(1.24±1.08),t=-2.396,P=0.019]。ESCC I期患者血清miR-222-5p水平低于ESCC II期和ESCC III期[(1.01±0.19)vs.(1.78±0.31)vs.(2.59±0.44),F=44.793,P<0.001];远处转移组ESCC患者血清miR-222-5p水平高于无远处转移组[(1.02±0.21)vs.(0.60±0.34),t=2.090,P=0.043];淋巴结转移组ESCC患者血清miR-222-5p水平高于无淋巴结转移组[(1.04±0.32)vs.(0.79±0.39),t=2.223,P=0.032];男性组和女性组ESCC患者血清miR-222-5p水平比较,差异无统计学意义[(1.01±1.33)vs.(1.07±1.61),t=-0.123,P=0.903];≤65岁组和>65岁组ESCC患者血清miR-222-5p水平比较,差异无统计学意义[(1.09±0.53)vs.(1.06±0.67),t=0.145,P=0.885];ESCC治疗前组患者血清miR-222-5p水平高于ESCC治疗后组[(2.46±1.65)vs.(1.85±0.99),t=2.141,P=0.035]。ROC曲线分析显示,血清miR-222-5p为0.393时诊断ESCC效能最高,此时的敏感度和特异度分别为58.70%、80.60%。肿瘤组织miR-222-5p为0.435时诊断ESCC效能最高,此时敏感度和特异度分别为65.20%、78.30%。结论:川东北地区ESCC中miR-222-5p对肿瘤的发生和发展有一定预测作用,有较好的诊断效能。

    Abstract:

    Objective:To investigate the diagnostic efficacy of serum tumor markers for esophageal squamous cell carcinoma(ESCC)in northeast Sichuan province.Methods:The expression of miR-222-5p in esophageal tissues(observation group)and serum of 46 ESCC patients and 46 healthy subjects(control group)was detected by fluorescent quantitative PCR,and the relationship between the expression of serum miR-222-5p in ESCC and clinicopathological features was analyzed.Differential expression of miR-222-5p in tumor tissues and serum samples was analyzed by constructing receiver operating characteristic(ROC)curves to assess its diagnostic value for ESCC.Results:The serum level of miR-222-5p in the observation group was higher than that in the control group[(1.76±0.99)vs.(1.24±1.08),t=-2.396,P=0.019].The serum miR-222-5p level in ESCC stage Ⅰ was lower than that in ESCC stageⅡ and ESCC stage Ⅲ[(1.01±0.19)vs.(1.78±0.31)vs.(2.59±0.44),F=44.793,P<0.001].The level of serum miR-222-5p in ESCC patients with distant metastasis was higher than that in ESCC patients without distant metastasis[(1.02±0.21)vs.(0.60±0.34),t=2.090,P=0.043].The serum miR-222-5p level of ESCC patients with lymph node metastasis was higher than that of ESCC patients without lymph node metastasis[(1.04±0.32)vs.(0.79±0.39),t=2.223,P=0.032].There was no significant difference in serum miR-222-5p levels between male and female ESCC patients[(1.01±1.33)vs.(1.07±1.61),t=-0.123,P=0.903].There was no significant difference in serum miR-222-5p levels between ≤ 65 years old and>65 years old ESCC patients[(1.09±0.53)vs.(1.06±0.67),t=0.145,P=0.885].The serum miR-222-5p level in the pre-ESCC group was higher than that in the post-ESCC group[(2.46±1.65)vs.(1.85±0.99),t=2.141,P=0.035].ROC curve showed that when serum miR-222-5p was 0.393,the diagnostic efficacy of ESCC was the highest,the sensitivity was 58.70%,and the specificity was 80.60%.When miR-222-5p of tumor tissue was 0.435,the diagnostic efficacy of ESCC was the highest,and the sensitivity was 65.20%and the specificity was 78.30%.Conclusion:miR-222-5p has a certain predictive effect on the occurrence and development of ESCC in northeast Sichuan province,and shows moderate diagnostic efficacy.

    参考文献
    相似文献
    引证文献
引用本文

陈健;孟晶晶;张霖;贾科;.川东北地区食管鳞状细胞癌血清肿瘤标志物的诊断效能[J].川北医学院学报,2025,40(4):518-521.

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-07-24
  • 出版日期:
文章二维码